ctrl K

Deciphera Pharmaceuticals... (DCPH)

NASDAQ: DCPH · Real-Time Price · USD

25.59

0.02 (0.08%)

At close: Jun 10, 2024, 8:00 PM

Deciphera Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	163.36M	134.04M	96.15M	42.09M	25M	n/a	n/a	n/a
Cost of Revenue	3.73M	8.77M	2.93M	225K	830K	n/a	n/a	n/a
Gross Profit	159.62M	125.27M	93.22M	41.86M	24.17M	n/a	n/a	n/a
Operating Income	-210.96M	-182.72M	-300.08M	-271.19M	-200.73M	-104.1M	-50.94M	-25.84M
Interest Income	16.45M	4.51M	113K	4.7M	8.54M	4.33M	746K	n/a
Pretax Income	-194.51M	-178.21M	-299.96M	-266.49M	-192.26M	-99.85M	-50.28M	-25.94M
Net Income	-194.94M	-178.93M	-296.84M	-266.49M	-191.49M	-99.85M	-50.28M	-25.94M
Selling & General & Admin	136.46M	120.17M	136.25M	114.08M	68.12M	21.21M	11.42M	5.67M
Research & Development	234.12M	187.82M	257.04M	198.97M	157.61M	82.89M	39.51M	20.16M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4K
Operating Expenses	370.58M	307.99M	393.29M	313.05M	225.73M	104.1M	50.94M	25.84M
Interest Expense	n/a	4.51M	n/a	n/a	67K	84K	95K	106K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	374.31M	316.76M	396.23M	313.28M	225.73M	104.1M	50.94M	25.84M
Income Tax Expense	431K	722K	-3.13M	n/a	-763K	4.33M	746K	110K
Shares Outstanding (Basic)	85.06M	75.5M	58.08M	55.78M	42.87M	35.39M	16.79M	20.9M
Shares Outstanding (Diluted)	85.06M	75.5M	58.08M	55.78M	42.87M	35.39M	16.79M	20.9M
EPS (Basic)	-2.29	-2.37	-5.11	-4.78	-4.47	-2.82	-2.99	-1.24
EPS (Diluted)	-2.29	-2.37	-5.11	-4.78	-4.47	-2.82	-2.99	-1.24
EBITDA	-208.86M	-182.72M	-300.08M	-264.18M	-192.19M	-99.77M	-50.04M	-25.74M
EBIT	n/a	-173.7M	n/a	n/a	-192.19M	-99.77M	-50.19M	-25.83M
Depreciation & Amortization	2.1M	2.95M	3.01M	7.01M	8.54M	317K	150K	90K